β-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS
2011

Effects of β-Elemene Piperazine Derivatives on Leukemia Cells

publication Evidence: moderate

Author Information

Author(s): Yu Zhiying, Wang Rui, Xu Liying, Xie Siwei, Dong Jinhua, Jing Yongkui

Primary Institution: Shenyang Pharmaceutical University, Shenyang, China; The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, USA

Hypothesis

The study investigates whether novel β-elemene piperazine derivatives can induce apoptosis in human leukemia cells through specific mechanisms.

Conclusion

The novel β-elemene piperazine derivatives induce apoptosis in leukemia cells by downregulating c-FLIP levels and generating reactive oxygen species (ROS).

Supporting Evidence

  • The derivatives DX1, DX2, and DX5 were more effective in inducing apoptosis than DX3 and DX4.
  • DX1 treatment led to increased production of hydrogen peroxide and decreased mitochondrial membrane potential.
  • The activation of caspase-8 was correlated with the decrease in c-FLIP levels.

Takeaway

Researchers created new versions of a natural compound to see if they could make leukemia cells die. They found that some of these new compounds worked really well.

Methodology

The study synthesized five β-elemene piperazine derivatives and tested their effects on human leukemia cell lines, measuring cell growth inhibition and apoptosis induction.

Limitations

The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0015843

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication